productfda

168 results found.

Top Stocks matching your search for "product fda"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 27, 2023

I think that's a good number considering all t... See more

Feb, 27, 2023

Super excited for tomorrow's ER Guidance Call ... See more

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 13, 2023

They have a great product treating cancer with imm... See more

Jan, 6, 2023

look into Adamis Pharma, no more speculation, now ... See more

Image with triangles

Divihomes is Now Live

A new search platform that matches you with the best home improvement service providers in your area.

Instant Search & Match with Top Contractors

Instant Communication with Local Contractors

Phone Image with DiviHomes website

Millions of Unbiased User Reviews

100% Free Quotes from Top-Notch Contractors

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
XERS

Xeris Biopharma Holdings Inc

15.52%

$1.16 - $1.34

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 17, 2023

$XERS their primary product increases 9% week to w... See more

Mar, 14, 2023

$XERS I like their products and the inject opportu... See more

TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 27, 2023

I think that's a good number considering all the work that goes into launching a product.

Feb, 27, 2023

Super excited for tomorrow's ER Guidance Call for our first ever FDA approved commercialized product, Briumvi!

Feb, 4, 2023

It’s not just the efficacy and safety of the product, it is the less cost for hospital/infusion, due to one hour infusion and the huge difference in price.

Jan, 4, 2023

Imagine how much Ubli could be worth to BP now with Briumvi’s best in class product profile.

Dec, 30, 2022

$TGTX This gonna be amazing guys after they sell their product Lets say 50.000 usd for the dose and they sell 500 a month Make the math and tell me how revenue they will get every quarter

Dec, 30, 2022

This is not some get rich scheme, this is a solid biotech company with an approved product that will bring in billions in revenue.

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 13, 2023

They have a great product treating cancer with immunotherapy, peer reviewed journal

Jan, 6, 2023

look into Adamis Pharma, no more speculation, now it's real, two FDA approved meds, two major products, top of the line in comparison of their rivals, for cheaper price, AND WITH NO MUCH COMPETITION!

Dec, 14, 2022

2023 is going to be very positive for patients of our products and shareholders alike

Dec, 6, 2022

Their product works (see the mad Pole Piotr’s graphs 😵‍💫) Multi year holds, the bodadem.

Dec, 5, 2022

We have great data out of a superior product,

Oct, 18, 2022

They have good products and a solid future.

XERS

Xeris Biopharma Holdings Inc

15.52%

$1.16 - $1.34

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 17, 2023

$XERS their primary product increases 9% week to week sales with an overall trend that's incredible.

Mar, 14, 2023

$XERS I like their products and the inject opportunity with Horizon Tepezza is huge I wish they weren't acquired so they can keep a focus on that.

Jan, 23, 2023

Earnings are growing and there could be great news any day from a variety of sources, whether a collab exercise of option, new product collab, royalty pmt, etc.

Jan, 5, 2023

More important is that they grow Recorlev's revenue at high(er) speed, and continue to gain market share with Gvoke without product price drop.

Jan, 1, 2023

Revenue exploding on the upside with their 4 products.

Dec, 23, 2022

Even if they have more short term gains coming soon, we know the Gvoke product will gain share back due to the more pleasant experience. Patience.

Dec, 23, 2022

Gvoke is the best and easiest product out there.

Dec, 13, 2022

Products have been approved and much more is coming, wait and relax.

Nov, 4, 2022

For a tiny company like xeris to go toe to toe with lilly and grow share shows they have the best product.

Nov, 2, 2022

$XERS Truly so strange, everything Xeris had in its programme has been met, briefly 3 FDA approved products, collaborations with major pharmacies and much, much more.